National Pharmaceutical Pricing Authority
-
{
- All
- News
- Videos
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
NPPA Fixes Retail Prices Of 30 Drug Formulations, Including Vitamin D3, Diabetes And Cardiac Medicines
The revised prices cover a range of formulations, including Vitamin D3 oral solutions, calcium supplements, diabetes therapies, cardiovascular drugs and antibiotics.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
Ceiling Prices Of Eight Drugs Used For Asthma, TB, Other Treatments Raised By 50%
Most of these drugs are low cost and generally used as first-line treatment crucial to the public health programmes of the country, the ministry says.
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
Merck Gets Demand Notice From Regulator
Merck said the government has issued the demand notice despite the fact that the company was neither a manufacturer nor a marketer of the subject drug.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Dr Reddy's Says Drug Price Cap May Not Impact Much: Report
A recent government order bringing in some more medicines under control may not have much impact on Hyderabad-based drug maker Dr Reddy's Laboratories in terms of product pricing, according to a senior company official.
-
Government Withdraws Regulator's Power to Cap Non-Essential Drug Prices
The National Pharmaceutical Pricing Authority (NPPA) said the government has withdrawn its power to set prices of nonessential medicines, but price caps on over 100 non-essential drugs that drew the industry's ire in July will remain.
-
Pharma Shares Gain as Government Curbs Regulator's Power
NPPA had capped prices of 108 non-essential drugs in July to improve its affordability, but the decision was greeted with protests and has been challenged in courts in India as prices of generic drugs are already low in India compared with other markets.
-
How Are You Capping Drug Prices in Absence of Guidelines: Court Asks NPPA
The Delhi High Court on Tuesday asked the National Pharmaceutical Pricing Authority (NPPA) to show the manner in which it is exercising its power to cap prices of non-scheduled drugs in view of the recent withdrawal of the guidelines issued for the purpose.
-
Decontrolling of Cardiac, Diabetes Drugs Prices Challenged in Supreme Court
The Centre's decision to decontrol prices of 108 cardiac and diabetes drugs was on Thsrday challenged before the Supreme Court which agreed to hear the case "as soon as possible".
-
Explained: Why Are Some Drugs Cheaper, Others Expensive For Cancer?
Price reductions have been seen in drugs that are used to treat different cancers. However, the price cuts have not been uniform. Several expensive medicines have remained unchanged. This raises an important question: why do some cancer drugs cost much less while others continue to be expensive.
-
Cancer Drug Prices Slashed: New Rates For 543 Drug Brands From November 9
The new MRPs will apply from November 9, 2026. The NPPA's latest list is based on the price information submitted by companies until October 27.
-
NPPA Fixes Retail Prices Of 30 Drug Formulations, Including Vitamin D3, Diabetes And Cardiac Medicines
The revised prices cover a range of formulations, including Vitamin D3 oral solutions, calcium supplements, diabetes therapies, cardiovascular drugs and antibiotics.
-
Centre Cuts Prices Of 35 Essential Medicines
In a move to make medicines more affordable for patients, the National Pharmaceutical Pricing Authority (NPPA) has reduced the retail prices of 35 essential drugs sold by leading pharmaceutical companies.
-
Ceiling Prices Of Eight Drugs Used For Asthma, TB, Other Treatments Raised By 50%
Most of these drugs are low cost and generally used as first-line treatment crucial to the public health programmes of the country, the ministry says.
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
Merck Gets Demand Notice From Regulator
Merck said the government has issued the demand notice despite the fact that the company was neither a manufacturer nor a marketer of the subject drug.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Government To Amend Norms For Fixing Prices Of 350 Drugs In 15 Days
Drugs Prices Control Order will be amended in the next 15 days to enable the regulator NPPA to fix prices of about 350 medicines whose market data is not available, Union Minister Ananth Kumar said on Monday.
-
Dr Reddy's Says Drug Price Cap May Not Impact Much: Report
A recent government order bringing in some more medicines under control may not have much impact on Hyderabad-based drug maker Dr Reddy's Laboratories in terms of product pricing, according to a senior company official.
-
Government Withdraws Regulator's Power to Cap Non-Essential Drug Prices
The National Pharmaceutical Pricing Authority (NPPA) said the government has withdrawn its power to set prices of nonessential medicines, but price caps on over 100 non-essential drugs that drew the industry's ire in July will remain.
-
Pharma Shares Gain as Government Curbs Regulator's Power
NPPA had capped prices of 108 non-essential drugs in July to improve its affordability, but the decision was greeted with protests and has been challenged in courts in India as prices of generic drugs are already low in India compared with other markets.
-
How Are You Capping Drug Prices in Absence of Guidelines: Court Asks NPPA
The Delhi High Court on Tuesday asked the National Pharmaceutical Pricing Authority (NPPA) to show the manner in which it is exercising its power to cap prices of non-scheduled drugs in view of the recent withdrawal of the guidelines issued for the purpose.
-
Decontrolling of Cardiac, Diabetes Drugs Prices Challenged in Supreme Court
The Centre's decision to decontrol prices of 108 cardiac and diabetes drugs was on Thsrday challenged before the Supreme Court which agreed to hear the case "as soon as possible".
